{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T20:37:52Z","timestamp":1774471072746,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Drug-coated balloon (DCB) is a device for treating patients with in-stent restenosis; however, there are scant data on its efficacy for stent edge restenosis (SER). This study aimed to investigate the clinical outcomes of DCB use for treating SER compared with new-generation drug-eluting stent (DES) implantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>From December 2013 to January 2019, patients who underwent DES implantation or DCB for SER were enrolled. Clinical outcomes were analyzed, and propensity score with matching was conducted. The primary outcome was target-vessel revascularization (TVR). The secondary outcomes were the incidence of all-cause mortality, major adverse cardiovascular events (MACE), and target lesion revascularization (TLR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>A total of 291 patients with SER were included: 160 were treated with DCB, and 131 with new-generation DES. DCB treatment for SER treatment was associated with a lower risk of TVR than DES [hazard ratio, 0.549; 95% confidence interval (CI), 0.339\u20130.891] at a median follow-up of 1080\u2009days (interquartile range; 729\u20131080\u2009days). Propensity score matching (PSM) was performed to adjust for baseline clinical and lesion characteristics. After PSM, no significant difference in the risk of TVR was observed (hazard ratio, 0.965; 95% CI, 0.523\u20131.781). Similarly, the risk for all-cause death (hazard ratio, 0.507; 95% CI, 0.093\u20132.770), MACE (hazard ratio: 0.812; 95% CI, 0.451\u20131.462), and TLR (hazard ratio: 0.962; 95% CI, 0.505\u20131.833) were comparable between the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>DCB treatment efficacy for SER was similar to that of new-generation DES after PSM. DCB is a significant alternative to obtain comparable results with new-generation DES for the treatment of SER.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001235","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T11:02:53Z","timestamp":1679569373000},"page":"236-243","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Drug-coated balloons for the treatment of stent edge restenosis"],"prefix":"10.1097","volume":"34","author":[{"given":"Takashi","family":"Nagasaka","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Amanai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Aihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Takama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimichi","family":"Koitabashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12928-020-00734-7","article-title":"Mechanisms of drug-eluting stent restenosis.","volume":"36","author":"Aoki","year":"2021","journal-title":"Cardiovasc Interv Ther"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial.","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.4244\/EIJ-D-19-01031","article-title":"Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries.","volume":"17","author":"Tamez","year":"2021","journal-title":"EuroIntervention"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1253\/circj.CJ-12-1259","article-title":"Mechanism of edge restenosis after drug-eluting stent implantation. Angulation at the edge and mechanical properties of the stent.","volume":"77","author":"Kim","year":"2013","journal-title":"Circ J"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.amjcard.2005.06.066","article-title":"Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial).","volume":"96","author":"Sakurai","year":"2005","journal-title":"Am J Cardiol"},{"key":"R6-20250729","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004795","article-title":"Impact of stent size selection on acute and long-term outcomes after drug-eluting stent implantation in de novo coronary lesions.","volume":"10","author":"Kitahara","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"R7-20250729","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004231","article-title":"Optical coherence tomography predictors for edge restenosis after everolimus-eluting stent implantation.","volume":"9","author":"Ino","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1253\/circj.CJ-21-0196","article-title":"Effect of hinge motion on stent edge-related restenosis after right coronary artery treatment in the current drug-eluting stent era.","volume":"85","author":"Jimba","year":"2021","journal-title":"Circ J"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4244\/EIJ-D-20-00539","article-title":"Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis.","volume":"17","author":"Nakamura","year":"2021","journal-title":"EuroIntervention"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2021.08.003","article-title":"Impact of intravascular ultrasound on outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).","volume":"340","author":"Shlofmitz","year":"2021","journal-title":"Int J Cardiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCINTERVENTIONS.110.940320","article-title":"Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis: intravascular ultrasound analysis.","volume":"4","author":"Kang","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MCA.0000000000000945","article-title":"Characteristics of recurrent in-stent restenosis after second- and third-generation drug-eluting stent implantation.","volume":"32","author":"Shimono","year":"2021","journal-title":"Coron Artery Dis"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial.","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MCA.0000000000000796","article-title":"Drug-eluting balloons versus drug-eluting stents for small vessel coronary artery disease: a meta-analysis: a meta-analysis.","volume":"31","author":"Song","year":"2020","journal-title":"Coron Artery Dis"},{"key":"R16-20250729","first-page":"285","article-title":"Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: a systematic review and meta-analysis.","volume":"92","author":"Kokkinidis","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis.","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the International DCB Consensus Group.","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/01.CIR.78.2.486","article-title":"Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology\/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty).","volume":"78","author":"Ryan","year":"1988","journal-title":"Circulation"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jjcc.2016.12.019","article-title":"Drug-eluting balloons versus drug-eluting stents for the management of in-stent restenosis: a meta-analysis of randomized and observational studies.","volume":"70","author":"Wang","year":"2017","journal-title":"J Cardiol"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcin.2013.01.132","article-title":"Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.","volume":"6","author":"Gogas","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.amjcard.2013.01.288","article-title":"Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.","volume":"111","author":"Kang","year":"2013","journal-title":"Am J Cardiol"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.","volume":"104","author":"Kleber","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2021.01.049","article-title":"Serial assessment of de novo coronary lesions after drug-coated balloon treatment analyzed by intravascular ultrasound: a comparison between acute coronary syndrome and stable angina pectoris.","volume":"330","author":"Funayama","year":"2021","journal-title":"Int J Cardiol"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"766088","DOI":"10.3389\/fcvm.2021.766088","article-title":"Comparison of drug-coated balloon angioplasty vs. drug-eluting stent implantation for drug-eluting stent restenosis in the routine clinical practice: a meta-analysis of randomized controlled trials.","volume":"8","author":"Zhu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"1042329","DOI":"10.1155\/2020\/1042329","article-title":"Drug-coated balloons versus everolimus-eluting stents in patients with in-stent restenosis: a pair-wise meta-analysis of randomized trials.","volume":"2020","author":"Peng","year":"2020","journal-title":"Cardiovasc Ther"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2459\/JCM.0000000000000632","article-title":"Treatment of coronary artery disease with a new-generation drug-coated balloon: final results of the Italian Elutax SV rEgistry-DCB-RISE.","volume":"19","author":"Cortese","year":"2018","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.amjcard.2008.02.053","article-title":"Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).","volume":"101","author":"Costa","year":"2008","journal-title":"Am J Cardiol"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents.","volume":"10","author":"Kufner","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s12325-020-01320-2","article-title":"Systematic scoring balloon lesion preparation for drug-coated balloon angioplasty in clinical routine: results of the PASSWORD observational study.","volume":"37","author":"Bonaventura","year":"2020","journal-title":"Adv Ther"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1253\/circj.CJ-10-1182","article-title":"Impact of hinge motion on in-stent restenosis after sirolimus-eluting stent implantation.","volume":"75","author":"Ino","year":"2011","journal-title":"Circ J"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MCA.0b013e328341bb04","article-title":"Predictors of stent fracture in patients treated with closed-cell design stents: sirolimus-eluting stent and its bare-metal counterpart, the BX velocity stent.","volume":"22","author":"Park","year":"2011","journal-title":"Coron Artery Dis"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MCA.0b013e32833aa6a1","article-title":"Do drug elution components increase the risk of fracture of sirolimus-eluting stents?","volume":"21","author":"Kawai","year":"2010","journal-title":"Coron Artery Dis"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4244\/EIJV9I9A182","article-title":"Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents.","volume":"9","author":"O\u2019Sullivan","year":"2014","journal-title":"EuroIntervention"},{"key":"R36-20250729","first-page":"541","article-title":"Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap.","volume":"99","author":"Coughlan","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0735-1097(01)01760-0","article-title":"A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions.","volume":"39","author":"Serruys","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:02:57Z","timestamp":1753812177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001235","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}